Target-dependent reactions using structure-bridging oligonucleotides

• US 6,194,149 B1
• Filed: 03/03/1998
• Issued: 02/27/2001
• Est. Priority Date: 03/03/1998
• Status: Expired due to Term

• Current Assignee: Gen-Probe Incorporated (Hologic Incorporated)
• Original Assignee: Third Wave Technologies Incorporated (Hologic Incorporated)
• Inventors: Neri, Bruce, Dong, Fang, Lyamichev, Victor, Brow, Mary Ann D., Fors, Lance
• Primary Examiner(s): WHISENANT, ETHAN C
• Application Number:
  US09/034,205
• Time in Patent Office: 1,092 Days
• Field of Search: 435/6, 536/23.1, 536/24.3, 935/76, 935/77, 935/78
• US Class Current: 435/6.18
• CPC Class Codes: C12Q 1/6816 characterised by the detection means C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 1/701 Specific hybridization probes
• CPC Class Codes: C12Q 2521/301 Endonuclease
• CPC Class Codes: C12Q 2525/161 incorporating target specific and non-target specific sites
• CPC Class Codes: C12Q 2525/301 Hairpin oligonucleotides

Abstract

The present invention relates to methods and compositions for analyzing nucleic acids. In particular, the present invention provides methods and compositions for the detection and characterization of nucleic acid sequences and sequence changes. The methods of the present invention permit the detection and/or identification of genetic polymorphism such as those associated with human disease and permit the identification of pathogens (e.g., viral and bacterial strain identification).

Claims

1. A method, comprising:

a) providing;

i) target nucleic acid comprising first and second non-contiguous single-stranded regions separated by an intervening region comprising a double-stranded region;

ii) a bridging oligonucleotide capable of binding to said first and second non-contiguous single-stranded regions;

iii) a second oligonucleotide capable of binding to a portion of said first non-contiguous single-stranded region; and

iii) a cleavage means;

b) mixing said target nucleic acid, said bridging oligonucleotide, said second oligonucleotide, and said cleavage means under conditions such that a cleavage structure is formed and either said second oligonucleotide or said bridging oligonucleotide is cleaved.

2. The method of claim 1, wherein said cleavage means comprises a nuclease.

3. The method of claim 2, wherein said nuclease comprises a thermostable 5′

nuclease.

4. The method of claim 3, wherein said thermostable 5′

nuclease comprises an altered polymerase derived from a native polymerases of Thermus species.

5. The method of claim 1, wherein said conditions of said mixing allow for hybridization of said bridging oligonucleotide and said second oligonucleotide to said target nucleic acid so as to define a region of overlap of said oligonucleotides.

6. The method of claim 5, wherein said region of overlap comprises one base.

7. The method of claim 5, wherein said region of overlap comprises more than one base.

8. The method of claim 1, wherein said target nucleic acid is DNA.

9. The method of claim 8, wherein said DNA is viral DNA.

10. The method of claim 9, wherein said viral DNA is derived from a virus which virus is selected from the group consisting of Parvoviridae, Papovaviridae, Adenoviridae, Hepadnaviridae, Herpesviridae, Iridoviridae, and Poxviridae.

11. The method of claim 1, wherein said target nucleic acid is RNA.

12. The method of claim 11, wherein said RNA is viral RNA.

13. The method of claim 12, wherein said viral DNA is derived from a virus which virus is selected from the group consisting of Picornaviridae, Caliciviridae, Reoviridae, Togaviridae, Flaviviridae, Orthomyxoviridae, Paramyxoviridae, Arenaviridae, Rhabdoviridae, Coronaviridae, Bunyaviridae, and Retroviridae.